Adicet Bio, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold ACET, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
12
Funds holding
$9028667
Total value held
Buying
7 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Franklin Resources Inc | $5413573 | 626571 | — | Held |
| 2 | Carlyle Group Inc. | $1592308 | 184295 | +184295 | NEW BUY |
| 3 | Blackrock, Inc. | $536769 | 62126 | +25541 | +69.81% |
| 4 | Regeneron Pharmaceuticals, Inc. | $522819 | 60511 | +60511 | NEW BUY |
| 5 | State Street Corp | $312958 | 36222 | — | Held |
| 6 | Ubs Group Ag | $257619 | 29817 | +29817 | NEW BUY |
| 7 | Johnson & Johnson | $196811 | 22779 | — | Held |
| 8 | Northern Trust Corp | $159287 | 18436 | -764 | -3.98% |
| 9 | Morgan Stanley | $19795 | 2291 | -1202 | -34.41% |
| 10 | Royal Bank Of Canada | $15000 | 1701 | +2 | +0.12% |
| 11 | Jpmorgan Chase & Co | $1677 | 196 | +188 | +2350.00% |
| 12 | Amalgamated Financial Corp. | $51 | 2529 | +2529 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.